GlucoTrack EBITDA 2011-2024 | GCTK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GlucoTrack ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GlucoTrack ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$202.2B
Stryker (SYK)	$143.3B
Boston Scientific (BSX)	$130.1B
Medtronic (MDT)	$112.5B
EssilorLuxottica (ESLOY)	$111.7B
Lonza Group Ag (LZAGY)	$45.4B
Haleon (HLN)	$43.5B
GE HealthCare Technologies (GEHC)	$39.3B
ResMed (RMD)	$37B
Terumo (TRUMY)	$29.6B
Koninklijke Philips (PHG)	$25B
Zimmer Biomet Holdings (ZBH)	$21.5B
Insulet (PODD)	$18.8B
Baxter (BAX)	$17.7B
Smith & Nephew SNATS (SNN)	$10.6B
Bio-Rad Laboratories (BIO)	$10.3B
BellRing Brands (BRBR)	$9.1B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$6.1B
Haemonetics (HAE)	$4.5B
TG Therapeutics (TGTX)	$4.5B
ICU Medical (ICUI)	$4.3B
Prestige Consumer Healthcare (PBH)	$4B
Perrigo (PRGO)	$3.6B
Neogen (NEOG)	$3.5B
Envista Holdings (NVST)	$3.5B
Agios Pharmaceuticals (AGIO)	$3.4B
GN Store Nord (GNNDY)	$3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B